newsfilter
← Latest News
GlobeNewswire·

Results of Annual General Meeting

DUBLIN, Ireland, and Boston MA, July 1, 2022, Amryt (NASDAQ:AMYT), a global, commercial-stage biopharmaceutical company focussed on acquiring, developing and commercializing novel treatments for rare diseases, is pleased to announce that all resolutions